Logo
B

Better Therapeutics

35 employees

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Basic info

Industry

biotechnology

Sectors

Biotechnology
type 2 diabetes
Artificial Intelligence
diabetes
mHealth
digital therapeutics
research and development
prescription digital therapeutics
cardiometabolic conditions
Information Technology
cognitive behavioral therapy
heart disease
digital health
behavioral psychology
prescription software
lifestyle medicine
hyperlipidemia
chronic disease
Health Care
behavioral science
Therapeutics
disease reversal
neuroscience
hypertension

Date founded

2015

Funding rounds raised

Total raised

$70M

from 4 investors over 4 rounds

B

Better Therapeutics raised $70M on October 29, 2021

Investors: Sectoral Asset Management, Farallon Capital Management and Monashee Investment Management LLC

B

Better Therapeutics raised $50M on August 25, 2021

Investors: Hercules Capital, Inc.

FAQ